NYSE: CHCTCommunity Healthcare Trust Inc Stock
$17.72+0.18 (+1.03%)
Updated May 21, 2026
CHCT Price
$17.72
Fair Value Price
N/A
Market Cap
$506.29M
52 Week Low
$13.24
52 Week High
$18.22
P/E
161.09x
P/B
1.2x
P/S
3.5x
PEG
1.84x
Dividend Yield
10.76%
Revenue
$122.64M
Earnings
$6.06M
Gross Margin
80.5%
Operating Margin
27.32%
Profit Margin
4.9%
Debt to Equity
1.4
Operating Cash Flow
$56M
Beta
0.55
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CHCT Overview
Community Healthcare Trust Incorporated is a real estate investment trust (REIT) that owns various types of healthcare properties that are then leased to hospitals, doctors, healthcare systems, and other healthcare service providers in non-urban markets. Properties it owns include medical office buildings, physician clinics, outpatient diagnostic and treatment centers, and acute in-patient behavioral facilities, among others. Community Healthcare operates in Texas, Illinois, Florida, Ohio, and Massachusetts. The company was founded in 2014 and is headquartered in Franklin, TN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CHCT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
D
CHCT
Ranked#3 of 17
Ranked#3 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $13.27 | B | |
| $14.59 | C | |
| $5.16 | C |
Be the first to know about important CHCT news, forecast changes, insider trades & much more!
CHCT News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CHCT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CHCT ($17.72) is trading above its intrinsic value of $3.83, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CHCT is poor value based on its earnings relative to its share price (161.09x), compared to the US market average (19.67x)
P/E vs Market Valuation
CHCT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CHCT due diligence checks available for Premium users.
Valuation
CHCT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
161.09x
Industry
92.45x
Market
19.67x
CHCT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CHCT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CHCT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.2x
Industry
2.79x
CHCT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CHCT price to earnings growth (PEG)
For valuing profitable companies with growth potential
CHCT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CHCT's financial health
Profit margin
Revenue
$31.5M
Net Income
$2.5M
Profit Margin
8.1%
CHCT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.0B
Liabilities
$588.8M
Debt to equity
1.4
CHCT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CHCT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$13.7M
Investing
-$27.5M
Financing
$13.0M
CHCT vs Healthcare Facility REIT Stocks
Community Healthcare Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.